Presentation: Diversity of Therapeutic Approaches: Global Challenges, Opportunities, and Views from the United States, Europe, and Asia

Panel Discussion Abstract

The panel discussion recorded during ASGCT 2023 features three key opinion leaders from the United States, Europe and Asia who discuss significant challenges, opportunities and views from their geographies. Topics covered during the session include dialog about the diversity of cell types utilized, differing technological approaches and key regulatory & accessibility challenges they face during their journey to develop effective therapies.




Cenk Sumen, Ph.D. - Chief Scientific Officer, MaxCyte, Inc., USA

Steven A. Feldman, Ph.D. - Site Head and Scientific Director,  Laboratory for Cell and Gene Medicine, Stanford GMP Facility, USA

Akitsu Hotta, Ph.D. - Associate Professor / Principal Investigator, Department of Clinical Application, Centre for iPS Cell Research and Application (CiRA), Kyoto University, Japan

Paula Río, Ph.D. - Hematopoietic Innovative Therapies Division, CIEMAT/CIBERER/ IIS Fundación Jiménez Díaz, SPAIN

Continue to presentation

Please fill form below to continue to presentation.